Establishment of rat hepatocellular carcinoma cell lines with differing metastatic potential in nude mice. 2001

K Ogawa, and H Nakanishi, and F Takeshita, and M Futakuchi, and M Asamoto, and K Imaida, and M Tatematsu, and T Shirai
First Department of Pathology, Nagoya City University, Medical School, 1 Kawasumi, Mizuho-cho, Nagoya 467-8601, Japan. kogawa@med.nagoya-cu.ac.jp

For better understanding of cancer metastasis, we have established an in vivo model for induction of highly metastatic hepatocellular carcinomas (HCC) in male F344 rats. From 1 tumor, 4 cell lines with differing metastatic potential (C1, C2, C6, C5F) were established by subcloning using the limited-dilution cloning technique. Two other lines, N1 and L2, arose from another primary HCC and a lung metastatic lesion, respectively. Although cell adhesion of each cell line in culture medium was different, tumors developing in the subcutis of nude mice after transplantation were all moderately differentiated HCC with a trabecular pattern. On subcutaneous injection into nude mice, all 6 cell lines proved to be tumorigenic in the injection site and C5F was highly metastatic to the lung. With injection into the tail vein, N1 and L2 formed frequent metastases in the lung as well as in lymph nodes. Using intraperitoneal injection, C1, C6, N1 and L2 showed marked disseminated growth in the abdominal cavity with bloody ascitis. Northern blot analysis revealed expression of known metastasis-related genes, KAI1 and heparanase, to be decreased in C5F, but no differences in expression of nm23-H1 were evident. A point mutation in the GSK-3beta phosphorylation site of the beta-catenin gene was found in L2. These transplantable HCC cell lines that have different metastatic ability should be useful for elucidation of mechanisms of metastasis.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer

Related Publications

K Ogawa, and H Nakanishi, and F Takeshita, and M Futakuchi, and M Asamoto, and K Imaida, and M Tatematsu, and T Shirai
October 2001, World journal of gastroenterology,
K Ogawa, and H Nakanishi, and F Takeshita, and M Futakuchi, and M Asamoto, and K Imaida, and M Tatematsu, and T Shirai
January 2014, Asian Pacific journal of cancer prevention : APJCP,
K Ogawa, and H Nakanishi, and F Takeshita, and M Futakuchi, and M Asamoto, and K Imaida, and M Tatematsu, and T Shirai
January 1999, Surgery today,
K Ogawa, and H Nakanishi, and F Takeshita, and M Futakuchi, and M Asamoto, and K Imaida, and M Tatematsu, and T Shirai
August 2013, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
K Ogawa, and H Nakanishi, and F Takeshita, and M Futakuchi, and M Asamoto, and K Imaida, and M Tatematsu, and T Shirai
January 1979, Experimental cell biology,
K Ogawa, and H Nakanishi, and F Takeshita, and M Futakuchi, and M Asamoto, and K Imaida, and M Tatematsu, and T Shirai
March 1995, International journal of oncology,
K Ogawa, and H Nakanishi, and F Takeshita, and M Futakuchi, and M Asamoto, and K Imaida, and M Tatematsu, and T Shirai
September 1998, The Journal of urology,
K Ogawa, and H Nakanishi, and F Takeshita, and M Futakuchi, and M Asamoto, and K Imaida, and M Tatematsu, and T Shirai
May 2020, Scientific reports,
K Ogawa, and H Nakanishi, and F Takeshita, and M Futakuchi, and M Asamoto, and K Imaida, and M Tatematsu, and T Shirai
February 2014, Journal of translational medicine,
K Ogawa, and H Nakanishi, and F Takeshita, and M Futakuchi, and M Asamoto, and K Imaida, and M Tatematsu, and T Shirai
October 2001, World journal of gastroenterology,
Copied contents to your clipboard!